Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment [Forbes]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Forbes
Mounjaro and Zepbound, the pharmaceutical firm said Friday, as demand for the popular drugs has resulted in shortages. Demand for the company's weight loss and diabetes drugs has outpaced its supply. Eli Lilly will invest the funds to develop a manufacturing plant in Lebanon, Indiana, that will produce tirzepatide, the active ingredient in Zepbound and Mounjaro, the company The investment will add 200 full-time jobs at the site, including positions for engineers, scientists, operating personnel and lab technicians, bringing the total workforce at the site to 900 full-time employees, according to Eli Lilly. Production at the site is expected to begin toward the end of 2026, Eli Lilly said, with escalated operations through 2028. There is “limited availability” for most injections of Mounjaro and Zepbound in the U.S., to the Food and Drug Administration, citing increased demand for both drugs. Shares of Eli Lilly—up 39% this year—rose slightly to $808.69 after the announceme
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi [CNBC]CNBC
- Alzheimer's Disease Pipeline Landscape 2024: Comprehensive Insights About 110+ Companies and 120+ Drugs [Yahoo! Finance]Yahoo! Finance
- Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word. [Yahoo! Finance]Yahoo! Finance
- Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 6/14/24 - Form 144
- 6/11/24 - Form 4
- 6/10/24 - Form 4
- LLY's page on the SEC website